Male BRCA1 and BRCA2 GPV carriers are also at high risk for the development of BC, with risk estimates of ~1–5% and 5–10%, respectively, compared with the general male population, with a lifetime risk of ~0.1% [1]. This evidence concerns the gene BRCA1 and breast cancer.